Skip to main content

and
  1. No Access

    Article

    Molecular mechanisms by which splice modulator GEX1A inhibits leukaemia development and progression

    Splice modulators have been assessed clinically in treating haematologic malignancies exhibiting splice factor mutations and acute myeloid leukaemia. However, the mechanisms by which such modulators repress le...

    Mark Sellin, Ryan Mack, Matthew C. Rhodes, Lei Zhang in British Journal of Cancer (2022)